PROCTER & GAMBLE HEALTH
|
|
| BOM : 500126     NSE : PGHL     | |
| LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Jun 10,2026 |
|
Price(EOD): ₹ 6,256.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 10,385.54 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PROCTER & GAMBLE HEALTH | 0.9% | 18.7% | 11% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.4% | -4.6% | 6.9% |
| DIVIS LABORATORIES | 0.7% | -1.1% | 2.1% |
| TORRENT PHARMACEUTICALS | 2.9% | -1.2% | 42.7% |
| CIPLA | -1.5% | 5.5% | -6.5% |
| DR REDDYS LABORATORIES | 0.4% | -0.6% | 1.3% |
| MANKIND PHARMA | 0.7% | -4% | 1.9% |
| LUPIN | NA | 0.1% | 16.5% |
| ZYDUS LIFESCIENCES | 1.2% | 14.8% | 18.7% |
FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF PROCTER & GAMBLE HEALTH
 | Ratio | Standalone | |
|---|---|---|
|
P/E P/B P/S |
31.77
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 326.91 Cr
[Latest Qtr - Mar2026 - Standalone Results ] 19.8
P/B Calculated based on Book Value of Rs 524.55 Cr
[Latest Year - Mar2026 - Standalone Results ] 7.38
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2026 - Standalone Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
22% 41% 34% |
SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH
PROCTER & GAMBLE HEALTH vs SENSEX
DEBT OF PROCTER & GAMBLE HEALTH
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0 0 0 - |
- - - - |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF PROCTER & GAMBLE HEALTH
| Standalone | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-0.91% 22.75% 22.41% 21.92% |
19.12% 67.56% 69.63% 54.63% |
| QtrlyTrend |
6 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
PROCTER & GAMBLE HEALTH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 1% | 1% | 10.4% |
| BSE 1000 | -0.9% | -3.8% | -2.2% |
You may also like the below Video Courses
FAQ about PROCTER & GAMBLE HEALTH
Is PROCTER & GAMBLE HEALTH good for long term investment?
As on Jun 10,2026, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?
As on Jun 10,2026, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?
As on Jun 10,2026, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 4,676.31 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 5,113.11
Fair Value [Median EV / Sales Model] : Rs. 4,422.61
Fair Value [Median Price / Sales Model] : Rs. 4,676.31
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 4,676.31
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.